[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015 CompetitiveWatch: Nufarm in the Global Agrochemical Industry - Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

September 2015 | 33 pages | ID: C8D1928BF10EN
Venture Planning Group

US$ 1,960.00 US$ 2,450.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This strategic assessment of Nufarm, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market. SECTION I: EXECUTIVE SUMMARYA 3-5 page synopsis of key sections. SECTION II: BUSINESS ORGANIZATIONHistory of the companys agrochemical business evolution, which is important to understandingthe corporate culture, management mentality and strategies. Recent acquisitions, divestitures and major organizational changes. Current organizational structure. SECTION III: SENIOR MANAGEMENTNames, titles and background of key executives. SECTION IV: FACILITIES AND EMPLOYEESAdministrative, manufacturing and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. The U.S. and international work force size and distribution. SECTION V: TECHNOLOGICAL KNOW-HOWInternally developed and acquired agrochemical and related capabilities. Proprietary technologies and patent litigation. SECTION VI: PRODUCT PORTFOLIOReview of major product lines. Applications, advantages and weaknesses of leading products. SECTION VII: MARKETING TACTICSPromotional tactics. Distribution approaches. Product service and support. Customer relations. SECTION VIII: FINANCIAL ANALYSISEstimated sales by division, geographic region and product line. Five-year sales and operating profit performance. SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMSEstimated R&D budget. Research facilities and staff. New technologies, products and applications in development. SECTION X: COLLABORATIVE ARRANGEMENTSJoint ventures, distribution, O. E. M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. SECTION XI: STRATEGIC DIRECTIONSpecific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and divestitures. Contains 33 pages and 6 tables
SECTION I: EXECUTIVE SUMMARY

A 3-5 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION

History of the company’s orthopedics business evolution, important to the understanding of the corporate culture and strategies.
Most recent acquisitions, divestitures and organizational changes.
Current organizational structure.

SECTION III: SENIOR MANAGEMENT

Profiles of key executives.

SECTION IV: FACILITIES AND EMPLOYEES

Administrative, manufacturing and R&D
facilities in the U.S. and abroad.
Manufacturing practices.
New plants under construction.
U.S. and international workforce size and distribution.

SECTION V:TECHNOLOGICAL KNOW-HOW

Internally developed and acquired technologies.
Technical expertise in biotechnology, engineering and other perti¬nent fields.

SECTION VI: PRODUCT PORTFOLIO

Review of major product lines.
Specifications and features of current products.

SECTION VII: MARKETING TACTICS

The U.S. and international sales force size.
Distribution approaches.
Major promotional tactics.

SECTION VIII: FINANCIAL ANALYSIS

Five-year sales and operating profit performance.
Sales estimates by geographic region, market segment and product line.

SECTION IX: R&D EXPENDITURES AND MAJOR

R&D budget.
Research facilities and staff.
New technologies, products and applications in development

SECTION X: COLLABORATIVE ARRANGEMENTS

Major joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION

Business, new product development and marketing strategies.

LIST OF TABLES

Table EA-1: Aesculap Sales and Operating Profit Growth
Table EA-2: Aesculap Sales by Division
Table EA-3: Aesculap Sales Growth by Division
Table EA-4: Aesculap Sales by Geographic Region
Table EA-5: Aesculap Sales Growth by Geographic Region
Table AT-1: Arthrex Sales and Operating Profit Growth
Table AT-2: Arthrex Sales by Geographic Region
Table AT-3: Arthrex Sales Growth by Product Group
Table AT-4: Arthrex Sales by Product Line
Table AT-5: Arthrex Sales Growth by Product Line
Table BI-1: Biomet Sales and Operating Profit Growth
Table BI-2: Biomet Sales by Geographic Region
Table BI-3: Biomet Sales Growth by Product Group
Table BI-4: Biomet Sales by Product Line
Table BI-5: Biomet Sales Growth by Product Line
Table DJ-1: DJO Sales and Operating Profit Growth
Table DJ-2: DJO Sales by Geographic Region
Table DJ-3: DJO Sales Growth by Product Group
Table DJ-4: DJO Sales by Product Line
Table DJ-5: DJO Sales Growth by Product Line
Table JJ-1: J&J Sales by Geographic Region
Table JJ-2: J&J Medical Devices and Diagnostics Segment Sales by Business Segment
Table JJ-3: J&J Operating Profit by Business Segment
Table JJ-4: J&J Operating Profit Growth by Business Segment
Table JJ-5: J&J Sales by Business Segment and Geographic Region
Table JJ-6: J&J Sales by Geographic Region
Table JJ-7: J&J Sales Growth by Geographic Region
Table JJ-8: J&J Sales and Operating Profit Growth
Table ME-1: Medtronics Sales and Operating Profit Growth
Table ME-2: Medtronics Sales by Operating Segment
Table ME-3: Medtronics Sales Growth by Operating Segment
Table ME-4: Medtronics Sales by Geographic Region
Table ME-5: Medtronics Sales Growth by Geographic Region
Table SN-1: Smith & Nephew Sales and Operating Profit Growth
Table SN-2: Smith & Nephew Sales by Business Segment
Table SN-3: Smith & Nephew Sales Growth by Business Segment
Table SN-4: Smith & Nephew Operating Profit by Business Segment
Table SN-5: Smith & Nephew Operating Profit Growth by Business Segment
Table SN-6: Smith & Nephew Sales by Geographic Region
Table SN-7: Smith & Nephew Sales Growth by Geographic Region
Table ST-1: Stryker Sales and Operating Profit Growth
Table ST-2: Stryker Sales by Geographic Region/Country
Table ST-3: Stryker Sales Growth by Geographic Region/Country
Table ST-4: Stryker Sales by Product Line
Table ST-5: Stryker Sales Growth by Product Line
Table SY-1: Synthes Sales and Operating Profit Growth
Table SY-2: Synthes Sales by Geographic Region
Table SY-3: Synthes Sales by Product Group
Table ZH-1: Zimmer The Americas Sales by Product Category
Table ZH-2: Zimmer The Americas Sales Growth by Product Category
Table ZH-3: Zimmer Europe Sales by Product Category
Table ZH-4: Zimmer Asia Sales by Product Category


More Publications